Canada Markets open in 4 hrs 4 mins

Aptose Biosciences Inc. (APS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.2500-0.0600 (-1.81%)
At close: 3:59PM EDT
Full screen
Previous Close3.3100
Open3.3900
Bid3.2600 x N/A
Ask3.2700 x N/A
Day's Range3.2400 - 3.3900
52 Week Range3.2100 - 9.4000
Volume41,619
Avg. Volume42,661
Market Cap289.065M
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)-0.8680
Earnings DateAug. 03, 2021 - Aug. 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Aptose Reports Results for the Second Quarter 2021
    GlobeNewswire

    Aptose Reports Results for the Second Quarter 2021

    - Conference call and webcast at 5:00 pm EDT today - - Luxeptinib Phase 1a/b studies in AML and B cell malignancies fully enrolled at 750 mg dose - - APTO-253 Phase 1a/b study in AML / MDS treating patients at sixth dose cohort of 210 mg/m2 - SAN DIEGO and TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today an

  • Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
    Zacks

    Is a Beat in Store for Zoetis (ZTS) This Earnings Season?

    Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases second-quarter 2021 results.

  • We Think Aptose Biosciences (TSE:APS) Can Afford To Drive Business Growth
    Simply Wall St.

    We Think Aptose Biosciences (TSE:APS) Can Afford To Drive Business Growth

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...